Venrock Healthcare Capital Partners logo

Venrock Healthcare Capital Partners

North America, California, United States, Palo Alto

Description

Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies.

Investor Profile

Venrock Healthcare Capital Partners has made 76 investments, with 15 in the past 12 months and 28% as lead.

Stage Focus

  • Post Ipo Equity (51%)
  • Series B (20%)
  • Series A (13%)
  • Series C (12%)
  • Undisclosed (1%)
  • Series D (1%)
  • Series E (1%)

Country Focus

  • United States (80%)
  • Canada (4%)
  • France (4%)
  • Switzerland (3%)
  • China (3%)
  • Ireland (3%)
  • Bermuda (1%)
  • Denmark (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Biopharma
  • Life Science
  • Medical Device
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Venrock Healthcare Capital Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 16
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 14
RTW Investments
North America, New York, United States, New York
Co-Investments: 17
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 18
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 22
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 16
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 19
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 20
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 15
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 18

Which angels does Venrock Healthcare Capital Partners often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 1
FB
North America, Ohio, United States, Columbus
Shared Deals: 1
BS
North America, Minnesota, United States, Minneapolis
Shared Deals: 1
SK
North America, California, United States, Los Angeles
Shared Deals: 1
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Venrock Healthcare Capital Partners?

Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityMar 24, 2025
Amount Raised: $175,000,000
Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityFeb 18, 2025
Amount Raised: $200,000,000
Timberlyne Therapeutics

San Diego, California, United States

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

BiopharmaBiotechnologyHealth Care
Series AJan 9, 2025
Amount Raised: $180,000,000
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
Cidara Therapeutics

San Diego, California, United States

Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityNov 21, 2024
Amount Raised: $105,000,000
Metsera

New York, New York, United States

Metsera is a biopharmaceutical company that develops medicines for obesity and metabolic diseases.

BiopharmaHealth CareMedicalPharmaceutical
Series BNov 13, 2024
Amount Raised: $215,000,000

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
UndisclosedOct 29, 2024
Amount Raised: $200,000,000
enGene

Vancouver, British Columbia, Canada

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

BiotechnologyDiabetesGeneticsHealth Care
Post Ipo EquityOct 25, 2024
Amount Raised: $43,188,771
Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000
Oruka Therapeutics

Waltham, Massachusetts, United States

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

BiotechnologyHealth CareMedical
Post Ipo EquitySep 3, 2024
Amount Raised: $275,000,000